The effects of TNF-β on GI and mucosal integrity was shown, so increasing levels of this pro-inflammatory cytokine is partly responsible to inducing therapeutic effects in obesity [38]. The gene discussed is LTA; the disease is obesity due to melanocortin 4 receptor deficiency.